Exportar registro bibliográfico


Metrics:

Effect of an Exercise Program on Lymphocyte Proliferative Responses of COPD Patients (2018)

  • Authors:
  • USP affiliated authors: SILVA, CIBELE CRISTINE BERTO MARQUES DA - FM ; DUARTE, ALBERTO JOSE DA SILVA - FM ; CARVALHO, CELSO RICARDO FERNANDES DE - FM ; BENARD, GIL - FM
  • Unidades: FM; FM; FM; FM
  • DOI: 10.1007/s00408-018-0107-9
  • Subjects: DOENÇA PULMONAR OBSTRUTIVA CRÔNICA; TREINAMENTO FÍSICO; IMUNIDADE
  • Agências de fomento:
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: Lung
    • ISSN: 0341-2040
    • Volume/Número/Paginação/Ano: v. 196, n. 3, p. 271-276, 2018
  • Informações sobre o DOI: 10.1007/s00408-018-0107-9 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo NÃO é de acesso aberto
    • Cor do Acesso Aberto: closed

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FERNANDES, Juliana Ruiz; SILVA, Cibele Cristine Berto Marques da; DUARTE, Alberto Jose da Silva; CARVALHO, Celso Ricardo; BENARD, Gil. Effect of an Exercise Program on Lymphocyte Proliferative Responses of COPD Patients. Lung, New York, v. 196, n. 3, p. 271-276, 2018. Disponível em: < http://dx.doi.org/10.1007/s00408-018-0107-9 > DOI: 10.1007/s00408-018-0107-9.
    • APA

      Fernandes, J. R., Silva, C. C. B. M. da, Duarte, A. J. da S., Carvalho, C. R., & Benard, G. (2018). Effect of an Exercise Program on Lymphocyte Proliferative Responses of COPD Patients. Lung, 196( 3), 271-276. doi:10.1007/s00408-018-0107-9
    • NLM

      Fernandes JR, Silva CCBM da, Duarte AJ da S, Carvalho CR, Benard G. Effect of an Exercise Program on Lymphocyte Proliferative Responses of COPD Patients [Internet]. Lung. 2018 ; 196( 3): 271-276.Available from: http://dx.doi.org/10.1007/s00408-018-0107-9
    • Vancouver

      Fernandes JR, Silva CCBM da, Duarte AJ da S, Carvalho CR, Benard G. Effect of an Exercise Program on Lymphocyte Proliferative Responses of COPD Patients [Internet]. Lung. 2018 ; 196( 3): 271-276.Available from: http://dx.doi.org/10.1007/s00408-018-0107-9

    Referências citadas na obra
    GOLD: Global Initiative for Chronic Obstructive Lung Disease I (2017) Global initiative for chronic obstructive lung disease. Pocket guide to COPD diagnosis, management, and prevention. A Guide for Health Care Professionals
    Patel JG, Nagar SP, Dalal AA (2014) Indirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United States. Int J Chron Obstr Pulm Dis 9:289–300. https://doi.org/10.2147/COPD.S57157
    Schroff P, Hitchcock J, Schumann C, Wells JM, Dransfield MT, Bhatt SP (2017) Pulmonary rehabilitation improves outcomes in chronic obstructive pulmonary disease independent of disease burden. Ann Am Thorac Soc 14(1):26–32. https://doi.org/10.1513/AnnalsATS.201607-551OC
    Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J, Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, Vogiatzis I, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, Troosters T, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, Puhan MA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P, Morgan M, Rutten-van Molken MP, Ries AL, Make B, Goldstein RS, Dowson CA, Brozek JL, Donner CF, Wouters EF, Rehabilitation AETFoP (2013) An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 188 (8):e13–e64. https://doi.org/10.1164/rccm.201309-1634ST
    Wedzicha JA, Seemungal TA (2007) COPD exacerbations: defining their cause and prevention. Lancet 370(9589):786–796. https://doi.org/10.1016/S0140-6736(07)61382-8
    Araujo MS, Baldi BG, Freitas CS, Albuquerque AL, Marques da Silva CC, Kairalla RA, Carvalho CR, Carvalho CR (2016) Pulmonary rehabilitation in lymphangioleiomyomatosis: a controlled clinical trial. Eur Respir J 47(5):1452–1460. https://doi.org/10.1183/13993003.01683-2015
    Soares A, Govender L, Hughes J, Mavakla W, de Kock M, Barnard C, Pienaar B, Janse van Rensburg E, Jacobs G, Khomba G, Stone L, Abel B, Scriba TJ, Hanekom WA (2010) Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation. J Immunol Methods 362(1–2):43–50. https://doi.org/10.1016/j.jim.2010.08.007
    Chetta A, Olivieri D (2012) The COPD assessment test in the evaluation of chronic obstructive pulmonary disease exacerbations. Expert Rev Respir Med 6(4):373–375. https://doi.org/10.1586/ers.12.37
    Hodge G, Mukaro V, Reynolds PN, Hodge S (2011) Role of increased CD8/CD28(null) T cells and alternative co-stimulatory molecules in chronic obstructive pulmonary disease. Clin Exp Immunol 166(1):94–102. https://doi.org/10.1111/j.1365-2249.2011.04455.x
    Paulin E, Brunetto AF, Carvalho CRF (2003) Efeitos de programa de exercícios físicos direcionado ao aumento da mobilidade torácica em pacientes portadores de doença pulmonar obstrutiva crônica. J Pneumol 29:287–294
    Sethi S, Murphy TF (2008) Infection in the pathogenesis and course of chronic obstructive pulmonary disease. New Engl J Med 359(22):2355–2365. https://doi.org/10.1056/NEJMra0800353
    Kelemen Z, Drozdovszky O, Kerti M, Balogh Z, Barta I, Antus B, Varga JT (2016) The effect of pulmonary rehabilitation on oxidative stress after acute exacerbation in COPD. Eur Respir J. https://doi.org/10.1183/13993003.congress-2016.PA3786
    van Ranst D, Stoop WA, Meijer JW, Otten HJ, van de Port IG (2014) Reduction of exacerbation frequency in patients with COPD after participation in a comprehensive pulmonary rehabilitation program. Int J Chron Obstr Pulm Dis 9:1059–1067. https://doi.org/10.2147/COPD.S69574
    de Araujo AL, Silva LC, Fernandes JR, Matias Mde S, Boas LS, Machado CM, Garcez-Leme LE, Benard G (2015) Elderly men with moderate and intense training lifestyle present sustained higher antibody responses to influenza vaccine. Age 37(6):105. https://doi.org/10.1007/s11357-015-9843-4
    Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA (2011) The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol 11(9):607–615. https://doi.org/10.1038/nri3041
    Silva LC, de Araujo AL, Fernandes JR, Matias Mde S, Silva PR, Duarte AJ, Garcez Leme LE, Benard G (2016) Moderate and intense exercise lifestyles attenuate the effects of aging on telomere length and the survival and composition of T cell subpopulations. Age 38(1):24. https://doi.org/10.1007/s11357-016-9879-0
    Cosio MG, Majo J, Cosio MG (2002) Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest 121(5 Suppl):160S–165S
    Mathur S, Brooks D, Carvalho CR (2014) Structural alterations of skeletal muscle in COPD. Front Physiol 5:104. https://doi.org/10.3389/fphys.2014.00104
    Pera A, Campos C, Lopez N, Hassouneh F, Alonso C, Tarazona R, Solana R (2015) Immunosenescence: implications for response to infection and vaccination in older people. Maturitas 82(1):50–55. https://doi.org/10.1016/j.maturitas.2015.05.004
    Esensten JH, Helou YA, Chopra G, Weiss A, Bluestone JA (2016) CD28 costimulation: from mechanism to therapy. Immunity 44(5):973–988. https://doi.org/10.1016/j.immuni.2016.04.020
    Almans R, Bermejo-Martin JF (2011) Viral infection, adaptive immunity, and COPD. Clin Pulm Med 18(4):5
    McKendry RT, Spalluto CM, Burke H, Nicholas B, Cellura D, Al-Shamkhani A, Staples KJ, Wilkinson TM (2016) Dysregulation of antiviral function of CD8(+) T cells in the chronic obstructive pulmonary disease lung. Role of the PD-1-PD-L1 axis. Am J Respir Crit Care Med 193(6):642–651. https://doi.org/10.1164/rccm.201504-0782OC
    Kawayama T, Kinoshita T, Matsunaga K, Kobayashi A, Hayamizu T, Johnson M, Hoshino T (2016) Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls. Int J Chron Obstr Pulm Dis 11:295–303. https://doi.org/10.2147/COPD.S95686
    Wang J, Urbanowicz RA, Tighe PJ, Todd I, Corne JM, Fairclough LC (2013) Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD). PLoS ONE 8(3):e58556. https://doi.org/10.1371/journal.pone.0058556
    Gadgil A, Duncan SR (2008) Role of T-lymphocytes and pro-inflammatory mediators in the pathogenesis of chronic obstructive pulmonary disease. Int J Chron Obstr Pulm Dis 3(4):531–541
    Fan VS, Gharib SA, Martin TR, Wurfel MM (2016) COPD disease severity and innate immune response to pathogen-associated molecular patterns. Int J Chron Obstr Pulm Dis 11:467–477. https://doi.org/10.2147/COPD.S94410
    Kruger K, Seimetz M, Ringseis R, Wilhelm J, Pichl A, Couturier A, Eder K, Weissmann N, Mooren FC (2017) Exercise training reverses inflammation and muscle wasting after tobacco smoke exposure. Am J Physiol Regul Integr Comp Physiol 00316:02017. https://doi.org/10.1152/ajpregu.00316.2017
    Givi ME, Redegeld FA, Folkerts G, Mortaz E (2012) Dendritic cells in pathogenesis of COPD. Curr Pharm Des 18(16):2329–2335
    Vlahos R, Bozinovski S (2014) Role of alveolar macrophages in chronic obstructive pulmonary disease. Front Immunol 5:435. https://doi.org/10.3389/fimmu.2014.00435
    de Araujo AL, Silva LC, Fernandes JR, Benard G (2013) Preventing or reversing immunosenescence: can exercise be an immunotherapy? Immunotherapy 5(8):879–893. https://doi.org/10.2217/imt.13.77

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2020